[go: up one dir, main page]

FR2887447A1 - Utilisation d'un peptide comme principe actif amincissant - Google Patents

Utilisation d'un peptide comme principe actif amincissant

Info

Publication number
FR2887447A1
FR2887447A1 FR0603298A FR0603298A FR2887447A1 FR 2887447 A1 FR2887447 A1 FR 2887447A1 FR 0603298 A FR0603298 A FR 0603298A FR 0603298 A FR0603298 A FR 0603298A FR 2887447 A1 FR2887447 A1 FR 2887447A1
Authority
FR
France
Prior art keywords
peptide
active ingredient
slimming active
pro
slimming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR0603298A
Other languages
English (en)
Other versions
FR2887447B1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Societe dExtraction des Principes Actifs SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExtraction des Principes Actifs SA filed Critical Societe dExtraction des Principes Actifs SA
Priority to FR0603298A priority Critical patent/FR2887447B1/fr
Publication of FR2887447A1 publication Critical patent/FR2887447A1/fr
Application granted granted Critical
Publication of FR2887447B1 publication Critical patent/FR2887447B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention a pour objet l'utilisation d'au moins un peptide de séquence (AA)n-Pro-Gly-Pro-(AA)n, dans laquelle (AA) est un quelconque acide aminé ou un de ses dérivés, n étant un entier compris entre 0 et 3, en tant qu'agent actif, dans ou pour la préparation d'une composition cosmétique et/ou dennatologique et/ou pharmaceutique. L'invention comprend l'utilisation de ce peptide afin de traiter la cellulite et/ou son utilisation afin de réduire, éliminer ou prévenir les surcharges graisseuses sous-cutanées.
FR0603298A 2005-04-15 2006-04-13 Utilisation d'un peptide comme principe actif amincissant Expired - Fee Related FR2887447B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0603298A FR2887447B1 (fr) 2005-04-15 2006-04-13 Utilisation d'un peptide comme principe actif amincissant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0503762A FR2884418B1 (fr) 2005-04-15 2005-04-15 Utilisation d'un peptide comme principe actif amincissant
FR0603298A FR2887447B1 (fr) 2005-04-15 2006-04-13 Utilisation d'un peptide comme principe actif amincissant

Publications (2)

Publication Number Publication Date
FR2887447A1 true FR2887447A1 (fr) 2006-12-29
FR2887447B1 FR2887447B1 (fr) 2010-08-13

Family

ID=35414922

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0503762A Expired - Fee Related FR2884418B1 (fr) 2005-04-15 2005-04-15 Utilisation d'un peptide comme principe actif amincissant
FR0603298A Expired - Fee Related FR2887447B1 (fr) 2005-04-15 2006-04-13 Utilisation d'un peptide comme principe actif amincissant

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR0503762A Expired - Fee Related FR2884418B1 (fr) 2005-04-15 2005-04-15 Utilisation d'un peptide comme principe actif amincissant

Country Status (3)

Country Link
EP (1) EP1874328A1 (fr)
FR (2) FR2884418B1 (fr)
WO (1) WO2006108963A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014091147A2 (fr) 2012-12-11 2014-06-19 Isp Investments Inc. Utilisation cosmetique de l'association d'un extrait de germe de caroube et de cafeine en tant qu'agent actif amincissant
WO2014091146A2 (fr) 2012-12-11 2014-06-19 Isp Investments Inc. Utilisation cosmetique d'un extrait de germe de caroube en tant qu'agent actif amincissant
WO2018048892A1 (fr) 2016-09-07 2018-03-15 Isp Investments Llc Procédé d'augmentation de la lipolyse au moyen d'une composition comprenant un extrait de nelumbo nucifera (lotus) bioactif
EP3970691A1 (fr) 2020-09-18 2022-03-23 C.F.E.B. Sisley Compositions cosmétiques amincissantes contenant un ou plusieurs limonoïdes

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2940042A3 (fr) * 2006-06-13 2016-02-17 Helix Biomedix Inc. Fragments de peptides pour induire la synthèse de protéines de matrice extracellulaire
DK2125878T3 (da) 2007-01-05 2013-05-27 Helix Biomedix Inc Korte bioaktive peptider til cellulær og immunologisk modulation
ES2567706T3 (es) 2007-10-29 2016-04-26 Helix Biomedix Inc. Tetrapéptidos protectores para cuidado cutáneo

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673374A1 (fr) * 1991-03-01 1992-09-04 Oreal Composition cosmetique contenant comme ingredient actif un peptide a activite opiouide.
EP0816377A2 (fr) * 1996-06-28 1998-01-07 Bayer Corporation Peptides de liaison de la thrombine et prothrombine.
FR2761602A1 (fr) * 1997-04-02 1998-10-09 Sederma Sa Compositions cosmetiques amincissantes
US20040202677A1 (en) * 2003-04-10 2004-10-14 Hopkins Kevin J. Method of enhanced regional body fat reduction

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673374A1 (fr) * 1991-03-01 1992-09-04 Oreal Composition cosmetique contenant comme ingredient actif un peptide a activite opiouide.
EP0816377A2 (fr) * 1996-06-28 1998-01-07 Bayer Corporation Peptides de liaison de la thrombine et prothrombine.
FR2761602A1 (fr) * 1997-04-02 1998-10-09 Sederma Sa Compositions cosmetiques amincissantes
US20040202677A1 (en) * 2003-04-10 2004-10-14 Hopkins Kevin J. Method of enhanced regional body fat reduction

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; H. ARS ET AL: "Algae: sources of bio-natural active substances", XP002392108, accession no. 1997:322580 *
HADDOX J L ET AL: "BIOACTIVITY OF PEPTIDE ANALOGS OF THE NEUTROPHIL CHEMOATTRACANT, N-ACETYL-PROLINE-GLYCINE-PROLINE", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOCIATION FOR RESEARCH IN VISION AND, US, vol. 40, no. 10, September 1999 (1999-09-01), pages 2427 - 2429, XP000867492, ISSN: 0146-0404 *
PFISTER R R ET AL: "IDENTIFICATION AND SYNTHESIS OF CHEMOTACTIC TRIPEPTIDES FROM ALKALI-DEGRADED WHOLE CORNEA", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOCIATION FOR RESEARCH IN VISION AND, US, vol. 36, no. 7, June 1995 (1995-06-01), pages 1306 - 1316, XP000867490, ISSN: 0146-0404 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014091147A2 (fr) 2012-12-11 2014-06-19 Isp Investments Inc. Utilisation cosmetique de l'association d'un extrait de germe de caroube et de cafeine en tant qu'agent actif amincissant
WO2014091146A2 (fr) 2012-12-11 2014-06-19 Isp Investments Inc. Utilisation cosmetique d'un extrait de germe de caroube en tant qu'agent actif amincissant
US9962329B2 (en) 2012-12-11 2018-05-08 ISP Investments, LLC Cosmetic use of the combination of a carob germ extract and caffeine as a slimming active agent
WO2018048892A1 (fr) 2016-09-07 2018-03-15 Isp Investments Llc Procédé d'augmentation de la lipolyse au moyen d'une composition comprenant un extrait de nelumbo nucifera (lotus) bioactif
EP3970691A1 (fr) 2020-09-18 2022-03-23 C.F.E.B. Sisley Compositions cosmétiques amincissantes contenant un ou plusieurs limonoïdes
FR3114241A1 (fr) 2020-09-18 2022-03-25 C F E B Sisley Compositions cosmétiques amincissantes contenant un ou plusieurs limonoïdes

Also Published As

Publication number Publication date
FR2887447B1 (fr) 2010-08-13
FR2884418B1 (fr) 2008-11-21
WO2006108963A1 (fr) 2006-10-19
FR2884418A1 (fr) 2006-10-20
EP1874328A1 (fr) 2008-01-09

Similar Documents

Publication Publication Date Title
FR2887447A1 (fr) Utilisation d'un peptide comme principe actif amincissant
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
WO2003066001A3 (fr) Compositions de sels de zinc contre l'irritation des muqueuses dues a des spermicides et des microbicides
MA27908A1 (fr) Agents therapeutiques utiles pour le traitement de la douleur
BRPI0207700B8 (pt) mistura de conjugados monodispersa, composição farmacêutica, e, uso de uma mistura substancialmente monodispersa de um conjugado de polipeptídeo de insulina-oligômero
BR9906920A (pt) "tts contendo um antioxidante"
IT1254571B (it) Composizione farmaceutica per applicazione topica, quale smalto per unghie.
CA2335903A1 (fr) Nouvelle cyclosporine ayant un profil d'activite ameliore
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
NO20030411L (no) Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom
BR9914360A (pt) N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5
MA27305A1 (fr) Derives de 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene et leur utilisation en tant qu'inhibiteurs de renine dans le traitement de l'hypertension, de maladies cardiovasculaires ou renales
FR2857596B1 (fr) Utilisation d'une composition cosmetique ou pharmaceutique comprenant un extrait riche en lupeol, a titre de principe actif, pour stimuler la synthese des proteines de stress
BR112012028321A2 (pt) "compostos análogos de desazadesferrotiocina e desazadesferrotiocina poliéter como agentes de quelação de metal, composição farmacêutica e usos dos ditos compostos"
WO2005030753A3 (fr) Agents therapeutiques utiles pour traiter la douleur
EP1743623A3 (fr) Utilisation de composés d'urée pour favoriser la desquamation
MY139203A (en) Pharmaceutical composition
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
EP0354554A3 (fr) Compositions anti-irritantes et désensibilisantes et procédés de leur préparation
CA2319849A1 (fr) Utilisation de complexes inorganiques-organiques dans une composition
WO2002064552A8 (fr) DERIVE DE α-AMINO-N-HYDROXY-ACETAMIDE
FR2857597B1 (fr) Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
FR2773712B1 (fr) Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a
EP2308837A3 (fr) Dérivés d'acide hydroxamique substitués d'arylsulfonamido en tant qu'inhibiteurs de métalloprotéinases de matrice

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20141231